Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Zuo

Showing results (271-280 of 281) with videos related to

Pageof 29
Sort By:
Leukemia|December 15, 2018
Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphomaRou-Jun Peng, Bo-Wei Han, Qing-Qing Cai, et al.
Nature Communications|July 14, 2023
Chronic inflammation, neutrophil activity, and autoreactivity splits long COVIDMatthew C Woodruff, Kevin S Bonham, Fabliha A Anam, et al.
Journal of Hepatology|October 3, 2025
Targeting cell-state plasticity driven by FOXM1/CEBPB axis disrupts developmental heterogeneity and therapeutic resistance in hepatocellular carcinomaXiao-Feng Zhang, Xiao-Yu Zuo, Yun Zhu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2023
Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and RepositoryYu Zuo, Sherwin Navaz, Alex Tsodikov, et al.
Lupus|October 7, 2022
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")Zeynep B Erton, Rebecca K Leaf, Danieli de Andrade, et al.
Lupus|April 3, 2025
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository ("Registry")Zeynep Belce Erton, Rebecca K Leaf, Danieli de Andrade, et al.
Seminars in Arthritis and Rheumatism|January 7, 2024
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry")Cecile M Yelnik, Zeynep Belce Erton, Elodie Drumez, et al.
Annals of the Rheumatic Diseases|November 20, 2025
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository ('Registry')Jonathan Thaler, Michael Parides, Danieli Castro Oliveira de Andrade, et al.
Clinical and Experimental Rheumatology|July 30, 2025
Antiphospholipid antibody-related clinical manifestations during childhood versus adulthood: descriptive results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repositoryJheel Pandya Bhatt, Marissa Dale, Danieli Castro Oliveira de Andrade, et al.
JCI Insight|April 1, 2025
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infectionPei-Suen Tsou, Ramadan A Ali, Chenyang Lu, et al.
Pageof 29

Showing results (271-280 of 281) with videos related to

Sort By:
Pageof 29
Leukemia|December 15, 2018
Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphomaRou-Jun Peng, Bo-Wei Han, Qing-Qing Cai, et al.
Nature Communications|July 14, 2023
Chronic inflammation, neutrophil activity, and autoreactivity splits long COVIDMatthew C Woodruff, Kevin S Bonham, Fabliha A Anam, et al.
Journal of Hepatology|October 3, 2025
Targeting cell-state plasticity driven by FOXM1/CEBPB axis disrupts developmental heterogeneity and therapeutic resistance in hepatocellular carcinomaXiao-Feng Zhang, Xiao-Yu Zuo, Yun Zhu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2023
Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and RepositoryYu Zuo, Sherwin Navaz, Alex Tsodikov, et al.
Lupus|October 7, 2022
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")Zeynep B Erton, Rebecca K Leaf, Danieli de Andrade, et al.
Lupus|April 3, 2025
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository ("Registry")Zeynep Belce Erton, Rebecca K Leaf, Danieli de Andrade, et al.
Seminars in Arthritis and Rheumatism|January 7, 2024
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry")Cecile M Yelnik, Zeynep Belce Erton, Elodie Drumez, et al.
Annals of the Rheumatic Diseases|November 20, 2025
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository ('Registry')Jonathan Thaler, Michael Parides, Danieli Castro Oliveira de Andrade, et al.
Clinical and Experimental Rheumatology|July 30, 2025
Antiphospholipid antibody-related clinical manifestations during childhood versus adulthood: descriptive results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repositoryJheel Pandya Bhatt, Marissa Dale, Danieli Castro Oliveira de Andrade, et al.
JCI Insight|April 1, 2025
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infectionPei-Suen Tsou, Ramadan A Ali, Chenyang Lu, et al.
Pageof 29